MORGAN KAEGY: Open Payments
NPI 1972193639 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 50 payments from 19 companies in 2025. Trend: 2023 $3,888 · 2024 $4,307 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $497 |
| Lilly USA, LLC | 3 | $62 |
| ACADIA Pharmaceuticals Inc | 3 | $47 |
| UCB, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $45 |
| SK Life Science, Inc. | 2 | $44 |
| Grifols USA, LLC | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $31 |
| CSL Behring | 1 | $31 |
Products named: BOTOX, QULIPTA, NUPLAZID, Nayzilam, EMGALITY, VYEPTI, VYALEV, UBRELVY.
Industry payments across MO — which companies pay providers there.
